“Familial Hypercholesterolaemia in the Precision Medicine Era: Epidemiology, Genetics, Risk Stratification, and Therapeutic Innovations”. 2025. Diabzen 3 (3): 86-99. https://www.thediabzen.com/index.php/d/article/view/26.